In reaction to disappointing earnings/guidance: FDX -4.6%, RT -3.9%, ( reported Q2 same-restaurant sales and guest count results below prior guidance), JOY -2.8%, CFX -1.7%, HEI -1.7%, PNR -0.9%
M&A news: PHG -2.1% (to acquire VOLC for $18 per share)
Other news: NVGN -38.7% (raises A$4.1 mln in private placement), POZN -22.6% (announced that its investigational drug candidates YOSPRALA 81/40 and 325/40 have received a second complete response letter from the FDA), FRO -10% (cont volatility pre-mkt), UPS -1.4% (in sympathy with FDX earnings), HSBC -1% (still checking), MGM -0.8% (Macau gaming stocks weak overnight), GILD -0.8% (European healthcare cost regulator NICE terminates single technology appraisal of idelalisib (Zydelig))
Analyst comments: TSLA -2.3% ((at 7 month low as oil continues to sell off; hearing Morgan Stanley cutting estimates, target; remains Overweight)), SWIR -1.7% (downgraded to Sector Perform at RBC Capital Mkts), CLF -1.6% (target lowered to $1 from $10 at Credit Suisse), POR -1.5% (downgraded to Hold from Buy at Deutsche Bank), HFC -0.8% (downgraded to Market Perform from Outperform at Wells Fargo), ED -0.7% (downgraded to Sell from Hold at Deutsche Bank)